Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
CCB
|
Eric M Sprink
CEO |
SELL
Open market or private sale
|
Direct | 8,778 Reduced 4.33% |
$1,009,031
$114.95 p/Share
|
Jan 05
2026 |
|
PUBM
|
Rajeev K. Goel
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 44,000 Reduced 100.0% |
$387,200
$8.8 p/Share
|
Jan 05
2026 |
|
VKTX
|
Marianna Mancini
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 57,661 Reduced 12.35% |
$1,945,482
$33.74 p/Share
|
Jan 05
2026 |
|
VKTX
|
Greg Zante
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 57,661 Reduced 23.29% |
$1,902,813
$33.0 p/Share
|
Jan 05
2026 |
|
VKTX
|
Brian Lian
President & CEO |
SELL
Open market or private sale
|
Direct | 233,409 Reduced 8.54% |
$7,875,219
$33.74 p/Share
|
Jan 05
2026 |
|
ZYME
|
Kenneth Galbraith
Chair & CEO |
SELL
Open market or private sale
|
Direct | 54,343 Reduced 21.95% |
$1,364,009
$25.1 p/Share
|
Jan 05
2026 |
|
ZYME
|
Jeffrey T L Smith
EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 10,538 Reduced 36.48% |
$264,503
$25.1 p/Share
|
Jan 05
2026 |
|
SRE
|
Jeffrey W Martin
Chairman, CEO and President |
SELL
Open market or private sale
|
Direct | 23,111 Reduced 99.99% |
$2,032,150
$87.93 p/Share
|
Jan 05
2026 |
|
ZYME
|
Paul Andrew Moore
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 20,110 Reduced 33.24% |
$504,761
$25.1 p/Share
|
Jan 05
2026 |
|
KMI
|
John W Schlosser
V.P. (President, Terminals) |
SELL
Open market or private sale
|
Direct | 6,166 Reduced 2.97% |
$169,503
$27.49 p/Share
|
Jan 05
2026 |
|
PGY
|
Das Sanjiv
President |
SELL
Open market or private sale
|
Direct | 3,945 Reduced 2.95% |
$90,695
$22.99 p/Share
|
Jan 05
2026 |
|
PGY
|
Evangelos Perros
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 9,750 Reduced 8.87% |
$224,152
$22.99 p/Share
|
Jan 05
2026 |
|
PUBM
|
Steven Pantelick
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 18,398 Reduced 39.08% |
$162,086
$8.81 p/Share
|
Jan 05
2026 |
|
W
|
Jon Blotner
Pres., Commercial & Operations |
SELL
Open market or private sale
|
Direct | 4,997 Reduced 4.5% |
$528,882
$105.84 p/Share
|
Jan 05
2026 |
|
NTSK
|
Sanjay Beri
CEO and Chairman |
SELL
Open market or private sale
|
Direct | 175,707 Reduced 100.0% |
$3,045,002
$17.33 p/Share
|
Jan 05
2026 |
|
CDLX
|
Nicholas Hollmeyer Lynton
Chief Legal & Privacy Officer |
SELL
Open market or private sale
|
Direct | 6,253 Reduced 4.84% |
$7,316
$1.17 p/Share
|
Jan 05
2026 |
|
NTSK
|
Andrew H Del Matto
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 38,616 Reduced 48.2% |
$669,601
$17.34 p/Share
|
Jan 05
2026 |
|
CDLX
|
Amit Gupta
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 5,807 Reduced 1.13% |
$6,794
$1.17 p/Share
|
Jan 05
2026 |
|
CDLX
|
Alexis De Sieno
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 8,607 Reduced 4.1% |
$10,070
$1.17 p/Share
|
Jan 05
2026 |
|
JOBY
|
Didier Papadopoulos
President of Aircraft OEM |
SELL
Open market or private sale
|
Direct | 6,429 Reduced 5.35% |
$100,485
$15.63 p/Share
|
Jan 05
2026 |
|
AIRO
|
John Uczekaj
President and COO |
SELL
Open market or private sale
|
Direct | 183 Reduced 0.82% |
$1,723
$9.42 p/Share
|
Jan 05
2026 |
|
PATH
|
Daniel Dines
CEO and Chairman |
SELL
Open market or private sale
|
Direct | 45,000 Reduced 0.16% |
$707,850
$15.73 p/Share
|
Jan 05
2026 |
|
GLPI
|
Steven Ladany
SVP Chief Development Officer |
SELL
Open market or private sale
|
Direct | 2,825 Reduced 3.81% |
$125,147
$44.3 p/Share
|
Jan 05
2026 |
|
DLPN
|
William Iv O'Dowd
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 3,000 Added 0.71% |
$4,860
$1.62 p/Share
|
Jan 05
2026 |
|
ETSY
|
Merilee Buckley
CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct | 5,636 Reduced 100.0% |
$329,367
$58.44 p/Share
|
Jan 05
2026 |
|
CYTK
|
Andrew Callos
EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 22.92% |
$904,200
$60.28 p/Share
|
Jan 05
2026 |
|
GLUE
|
Edmund Dunn
Principal Accounting Officer |
SELL
Open market or private sale
|
Direct | 1,039 Reduced 4.38% |
$15,761
$15.17 p/Share
|
Jan 05
2026 |
|
GLUE
|
Jennifer Champoux
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 2,629 Reduced 4.04% |
$39,881
$15.17 p/Share
|
Jan 05
2026 |
|
ALT
|
Catherine A. Sohn |
BUY
Open market or private purchase
|
Direct | 500 Added 25.0% |
$2,120
$4.24 p/Share
|
Jan 05
2026 |
|
GLUE
|
Philip Nickson
Chief Business & Legal Officer |
SELL
Open market or private sale
|
Direct | 3,155 Reduced 4.93% |
$47,861
$15.17 p/Share
|
Jan 05
2026 |
|
GLUE
|
Sharon Townson
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 3,155 Reduced 4.44% |
$47,861
$15.17 p/Share
|
Jan 05
2026 |
|
GLUE
|
Filip Janku
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 3,155 Reduced 4.04% |
$47,861
$15.17 p/Share
|
Jan 05
2026 |
|
GLUE
|
Markus Warmuth
President & CEO |
SELL
Open market or private sale
|
Direct | 10,135 Reduced 1.6% |
$153,747
$15.17 p/Share
|
Jan 05
2026 |
|
LAKE
|
James M. Jenkins
President, CEO & Exec. Chair |
BUY
Open market or private purchase
|
Direct | 1,126 Added 1.18% |
$9,998
$8.88 p/Share
|
Jan 05
2026 |
|
AGLE
|
Cameron Turtle
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 2.18% |
$473,250
$31.55 p/Share
|
Jan 02
2026 |
|
WVE
|
Chris Francis |
SELL
Open market or private sale
|
Direct | 9,375 Reduced 27.27% |
$152,906
$16.31 p/Share
|
Jan 02
2026 |
|
NTRA
|
Steven Leonard Chapman
CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct | 3,848 Reduced 2.74% |
$881,769
$229.15 p/Share
|
Jan 02
2026 |
|
NTRA
|
Solomon Moshkevich
PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct | 2,951 Reduced 2.33% |
$675,424
$228.88 p/Share
|
Jan 02
2026 |
|
EVCM
|
Matthew David Feierstein
President |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.48% |
$113,699
$11.37 p/Share
|
Jan 02
2026 |
|
WRBY
|
David Abraham Gilboa
Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 40.16% |
$561,500
$22.46 p/Share
|
Jan 02
2026 |
|
RM
|
Forager Fund, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 7,968 Reduced 0.73% |
$310,194
$38.93 p/Share
|
Jan 02
2026 |
|
TERN
|
Emil Kuriakose
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 1,155 Reduced 2.24% |
$45,021
$38.98 p/Share
|
Jan 02
2026 |
|
FLO
|
Ryals Mc Mullian
Chairman and CEO |
SELL
Open market or private sale
|
Indirect | 209,000 Reduced 0.0% |
$2,271,830
$10.87 p/Share
|
Jan 02
2026 |
|
PLTR
|
Lauren Elaina Friedman Stat
Director |
SELL
Open market or private sale
|
Direct | 3,400 Reduced 5.48% |
$616,590
$181.35 p/Share
|
Jan 02
2026 |
|
ATAI
|
Cosmo Feilding Mellen |
SELL
Open market or private sale
|
Direct | 39,594 Reduced 0.51% |
$154,416
$3.9 p/Share
|
Jan 02
2026 |
|
PINS
|
Malik Ducard
Chief Content Officer |
SELL
Open market or private sale
|
Direct | 2,293 Reduced 0.33% |
$60,030
$26.18 p/Share
|
Jan 02
2026 |
|
ACHR
|
Thomas Paul Muniz
CHIEF TECHNOLOGY OFFICER |
SELL
Open market or private sale
|
Direct | 125,000 Reduced 8.95% |
$1,000,000
$8.0 p/Share
|
Jan 02
2026 |
|
DSAC
|
Tim Hwang |
SELL
Open market or private sale
|
Indirect | 1,716 Reduced 0.0% |
$2,762
$1.61 p/Share
|
Jan 02
2026 |
|
PLTR
|
Ryan D. Taylor
Officer |
SELL
Open market or private sale
|
Direct | 12,000 Reduced 4.77% |
$2,176,200
$181.35 p/Share
|
Jan 02
2026 |
|
PLTR
|
Alexander D. Moore
Director |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 1.65% |
$3,477,200
$173.86 p/Share
|
Jan 02
2026 |